Potsdam Company Developing Drug to Reverse Age-Related Loss of Vision

POTSDAM — A pre-clinical research company  in Potsdam New York is developing an eye drop to prevent age-related loss of vision.

Kris M. Barnes is the CEO of LentoBio, which is focused on treating a condition called presbyopia. Part of the natural aging process, presbyopia is when the lens behind the cornea and pupil stiffens and causes loss of vision. Many people who experience the condition exhibit symptoms around age 40 or 50 and may end up needing glassesor contact lenses.